Phase 1/2 Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

NCT06984094 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

612

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV Infection
Human Metapneumovirus Infection
Parainfluenza Infection

Interventions

BIOLOGICAL: SCB-1019T
BIOLOGICAL: SCB-1022
BIOLOGICAL: SCB-1033
BIOLOGICAL: Placebo (saline)

Sponsor

Clover Biopharmaceuticals AUS Pty